ZA954990B - Interleukin-5 specific recombinant antibodies - Google Patents

Interleukin-5 specific recombinant antibodies

Info

Publication number
ZA954990B
ZA954990B ZA954990A ZA954990A ZA954990B ZA 954990 B ZA954990 B ZA 954990B ZA 954990 A ZA954990 A ZA 954990A ZA 954990 A ZA954990 A ZA 954990A ZA 954990 B ZA954990 B ZA 954990B
Authority
ZA
South Africa
Prior art keywords
interleukin
recombinant antibodies
specific recombinant
specific
heavy
Prior art date
Application number
ZA954990A
Other languages
English (en)
Inventor
Mark William Bodmer
Diljeet Singh Athwal
John Spencer Emtage
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Publication of ZA954990B publication Critical patent/ZA954990B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA954990A 1994-06-17 1995-06-15 Interleukin-5 specific recombinant antibodies ZA954990B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9412230A GB9412230D0 (en) 1994-06-17 1994-06-17 Interleukin-5 specific recombiant antibodies

Publications (1)

Publication Number Publication Date
ZA954990B true ZA954990B (en) 1996-12-17

Family

ID=10756925

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA954990A ZA954990B (en) 1994-06-17 1995-06-15 Interleukin-5 specific recombinant antibodies

Country Status (18)

Country Link
US (3) US5998586A (fi)
EP (1) EP0765392B1 (fi)
JP (1) JP3973682B2 (fi)
AT (1) ATE264389T1 (fi)
AU (1) AU694783B2 (fi)
CA (1) CA2192543C (fi)
CZ (1) CZ292295B6 (fi)
DE (1) DE69532889T2 (fi)
ES (1) ES2218546T3 (fi)
FI (1) FI965032A0 (fi)
GB (1) GB9412230D0 (fi)
HU (1) HU221641B1 (fi)
IL (1) IL114179A (fi)
NO (1) NO964808L (fi)
NZ (1) NZ287927A (fi)
SK (1) SK282625B6 (fi)
WO (1) WO1995035375A1 (fi)
ZA (1) ZA954990B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412230D0 (en) * 1994-06-17 1994-08-10 Celltech Ltd Interleukin-5 specific recombiant antibodies
USRE39548E1 (en) 1994-06-17 2007-04-03 Celltech R&D Limited Interleukin-5 specific recombinant antibodies
US7399837B2 (en) 1995-12-22 2008-07-15 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
JP2001523083A (ja) * 1994-12-23 2001-11-20 スミスクライン・ビーチャム・コーポレイション Ｉｌ−５により媒介される疾病の治療に有用な組み換えｉｌ−５アンタゴニスト
US5693323A (en) * 1994-12-23 1997-12-02 Smithkline Beecham Corporation Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
EE200100552A (et) 1999-04-23 2002-12-16 Pharmexa A/S Meetod kasvuteguri IL-5 aktiivsuse in vivo mahasurumiseks, IL-5 analoog, seda kodeeriv nukleiinhappefragment ning kasutamine immunogeense kompositsiooni valmistamiseks
MY157173A (en) 2006-05-25 2016-05-13 Glaxo Group Ltd Modified humanised anti-interleukin-18
AU2009228163B2 (en) 2008-03-28 2012-08-30 Glaxosmithkline Llc Methods of treatment
WO2010042562A2 (en) 2008-10-06 2010-04-15 Minerva Biotechnologies Corporation Muc1* antibodies
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CN104531812A (zh) 2010-10-01 2015-04-22 现代治疗公司 设计核酸及其使用方法
US9505826B2 (en) * 2010-12-22 2016-11-29 Teva Pharmaceuticals Australia Pty Ltd Modified antibody with improved half-life
WO2012135805A2 (en) 2011-03-31 2012-10-04 modeRNA Therapeutics Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
RU2707251C2 (ru) 2011-10-03 2019-11-25 Модерна Терапьютикс, Инк. Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
KR20140102759A (ko) 2011-12-16 2014-08-22 모더나 세라퓨틱스, 인코포레이티드 변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
EP2833892A4 (en) 2012-04-02 2016-07-20 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS AND PEPTIDES ASSOCIATED WITH ONCOLOGY
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
JP6144355B2 (ja) 2012-11-26 2017-06-07 モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． 化学修飾ｍＲＮＡ
CN104994874B (zh) * 2012-12-26 2017-04-12 安科协同公司 抗整联蛋白β1抗体组合物及其使用方法
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
TW201613615A (en) 2014-06-30 2016-04-16 Academia Sinica Antagonists for interleukin-17 receptor B (IL-17RB) and its ligand IL-17B for cancer therapy
CN107660213B (zh) 2015-02-10 2023-01-13 米纳瓦生物技术公司 人源化抗MUCl＊抗体
TWI750133B (zh) 2015-08-24 2021-12-21 美商葛蘭素史密斯克萊有限責任公司 生藥組成物
US11390671B2 (en) 2017-06-06 2022-07-19 Glaxosmithkline Llc Biopharmaceutical compositions and methods for pediatric patients
CN111065651B (zh) 2017-09-29 2023-07-14 江苏恒瑞医药股份有限公司 Il-5抗体、其抗原结合片段及医药用途
CN109942706A (zh) * 2017-12-21 2019-06-28 三生国健药业（上海）股份有限公司 结合人il-5的单克隆抗体、其制备方法和用途
US20220010008A1 (en) * 2018-12-12 2022-01-13 Shanghai Pharmaexplorer Co., Ltd. Anti-human interleukin 5(il-5) monoclonal antibody and use thereof
WO2020200099A1 (zh) 2019-03-29 2020-10-08 江苏恒瑞医药股份有限公司 包含抗il-5抗体的药物组合物及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH07563B2 (ja) * 1988-11-03 1995-01-11 シェリング・コーポレーション 好酸球増加症の予防または鎮静用薬剤
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
IL162181A (en) * 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
WO1992008474A2 (en) * 1990-11-20 1992-05-29 The National Heart & Lung Institute Treatment of lung diseases
JPH07505767A (ja) * 1992-02-06 1995-06-29 シェリング・コーポレーション ヒトインターロイキン−５に対するヒト化モノクローナル抗体の設計，クローン化および発現
ES2121078T3 (es) * 1992-02-19 1998-11-16 Schering Corp Clonacion y expresion de anticuerpos monoclonales humanizados contra interleuquina-4 humana.
GB9412230D0 (en) * 1994-06-17 1994-08-10 Celltech Ltd Interleukin-5 specific recombiant antibodies

Also Published As

Publication number Publication date
DE69532889D1 (de) 2004-05-19
JPH10501697A (ja) 1998-02-17
NO964808L (no) 1997-02-17
WO1995035375A1 (en) 1995-12-28
ES2218546T3 (es) 2004-11-16
SK160096A3 (en) 1997-06-04
ATE264389T1 (de) 2004-04-15
IL114179A (en) 2001-08-26
AU2680395A (en) 1996-01-15
US6734286B2 (en) 2004-05-11
US20020042089A1 (en) 2002-04-11
GB9412230D0 (en) 1994-08-10
EP0765392B1 (en) 2004-04-14
CZ371296A3 (cs) 1998-05-13
HU9603183D0 (en) 1997-01-28
FI965032A (fi) 1996-12-16
US6316227B1 (en) 2001-11-13
US5998586A (en) 1999-12-07
AU694783B2 (en) 1998-07-30
FI965032A0 (fi) 1996-12-16
CA2192543A1 (en) 1995-12-28
HU221641B1 (hu) 2002-12-28
HUT76672A (en) 1997-10-28
JP3973682B2 (ja) 2007-09-12
DE69532889T2 (de) 2005-03-10
CA2192543C (en) 2008-07-29
IL114179A0 (en) 1995-10-31
EP0765392A1 (en) 1997-04-02
NO964808D0 (no) 1996-11-13
CZ292295B6 (cs) 2003-08-13
SK282625B6 (sk) 2002-10-08
NZ287927A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
HU9603183D0 (en) Interleukin-5 specific recombinant antibodies
NO955167L (no) Monoklonalt anti-V-integrin-antistoff
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
AU8432498A (en) Human-cd28 specific monoclonal antibodies for antigen non-specific activation oft-lymphocytes
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
HUP9904620A3 (en) Purified sperm surface antigen,monoclonal antibody therefor and applications therefor
AU628948B2 (en) Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof
EP0578515A3 (en) Humanized monoclonal antibodies.
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
AU6031090A (en) Monoclonal antibodies against a tumor-associated antigen
BR9509902A (pt) Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
AU8547291A (en) Monoclonal antibodies against tenascin
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
AU5449390A (en) Monoclonal antibody against c-reactive protein
NO985281D0 (no) Monoklonalt antihumant MP52-antistoff
AU2002300457A1 (en) Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies
EP0668923A4 (en) MONOCLONAL ANTIBODY.
FI960566A0 (fi) Monoklonaalinen vasta-aine, joka tunnistaa välisolun pinta-antigeenin
BR1100555B1 (pt) anticorpos monoclonais humanizados.
IE901956L (en) Monoclonal antibody.
GB9212074D0 (en) Monoclonal antibody
AU4283793A (en) Monocyte adhesion protein and monoclonal antibody thereto
DK0778891T3 (da) Rekombinant monoklonalt antistof mod rhesus D (D7C2)
IE900922L (en) Monoclonal antibody